Dry extract of Ruscus aculeatus L., Rhizoma (butcher's broom root) + Hesperidin methylchalcone + Ascorbic acid (Vitamin C)
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Cyclo 3 Fort is a combination of three active substances: dry extract of Ruscus aculeatus L., Rhizoma (butcher's broom root), hesperidin methylchalcone, and ascorbic acid (Vitamin C).
Cyclo 3 Fort belongs to a group of medicines that affect venous elasticity. This medicine has a toning and protective effect on blood vessels - it improves venous wall tension, strengthens capillaries, and reduces blood vessel permeability.
Cyclo 3 Fort is used to treat symptoms related to venous insufficiency (feeling of heaviness in the lower limbs, pain) and as an adjunct in the treatment of hemorrhoids (piles).
Cyclo 3 Fort is intended for adult patients.
Before starting treatment with Cyclo 3 Fort, the patient should discuss it with their doctor or pharmacist.
If skin inflammation or subcutaneous thickening or skin ulcers occur, the patient should contact their doctor.
If sudden swelling of one or both lower limbs, heart failure, or kidney failure occurs, the patient should contact their doctor.
If diarrhea occurs, treatment should be discontinued and the doctor contacted (see section 4).
Venous circulation disorders: if discomfort and/or vessel fragility do not improve after 2 weeks of treatment, the patient should contact their doctor.
Hemorrhoid-related disorders: taking Cyclo 3 Fort cannot replace specialized treatment of other anal conditions. If hemorrhoids persist after a few days of treatment (no longer than a week), a medical consultation is necessary.
Ascorbic acid (Vitamin C) may affect the results of certain laboratory tests, such as glucose, bilirubin, aminotransferase, lactate dehydrogenase, and other indicators.
This medicine should not be used in children and adolescents.
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
Cyclo 3 Fort contains ascorbic acid. Caution should be exercised when using it with deferoxamine and deferiprone (medicines used in particular for diseases caused by excess iron or aluminum in the body).
No studies have been conducted on interactions with other medicines.
No studies have been conducted on interactions with food, drink, and alcohol.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
As a precaution, Cyclo 3 Fort should be avoided during pregnancy.
The medicine should not be taken during breastfeeding.
There is no data on the effect of the medicine on fertility.
No studies have been conducted on the effect of Cyclo 3 Fort on the ability to drive and use machines.
Cyclo 3 Fort containsorange yellow FCF (E 110). The medicine may cause allergic reactions.
This medicine should always be taken exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The medicine is indicated for use in adults.
For the treatment of symptoms related to venous insufficiency (feeling of heaviness in the lower limbs, pain), it is recommended to take Cyclo 3 Fort in a dose of 2 to 3 capsules per day.
The patient can take one capsule in the morning and one in the evening or two capsules in the morning and one in the evening.
As an adjunct in the treatment of hemorrhoid-related symptoms, Cyclo 3 Fort is used in a dose of 4 to 5 capsules per day. The patient can take two capsules in the morning and two in the evening or three capsules in the morning and two in the evening.
The medicine should be taken orally.
The capsules should be swallowed with a glass of water.
The medicine is indicated for use in adults.
Excessive doses of ascorbic acid (Vitamin C), which is one of the ingredients of the medicine, may cause hemolytic anemia in people with a deficiency of the enzyme glucose-6-phosphate dehydrogenase (G6PD).
Taking ascorbic acid in a dose higher than 1g per day may cause the formation of kidney stones (formation of deposits in the urinary tract made of calcium oxalate crystals).
A double dose should not be taken to make up for a missed dose.
If the patient has any further doubts about the use of this medicine, they should consult their doctor or pharmacist.
Like all medicines, Cyclo 3 Fort can cause side effects, although not everybody gets them.
Side effects that may occur:
Feeling of cold in the limbs.
Pain in the veins (venous sensitivity).
Gastrointestinal disorders.
Aphthous stomatitis (gingivitis with the presence of vesicles).
Increased activity of alanine aminotransferase (liver enzyme).
Ascorbic acid affects the results of some laboratory tests.
If any side effects occur, including any side effects not listed in the leaflet, the patient should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl
Reporting side effects can help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the packaging.
The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste containers. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substances of the medicine are:
150 mg of dry extract of Ruscus aculeatus L., Rhizoma (butcher's broom root) (5-7.5:1)
Solvent: ethanol 85% (V/V)
Hesperidin methylchalcone 150 mg
Ascorbic acid (Vitamin C) 100 mg
Other ingredients are:
Capsule contents: talc, magnesium stearate, colloidal hydrophobic silica, macrogol 6000.
Capsule shell composition:
Body (yellow) - quinoline yellow (E 104), orange yellow FCF (E 110), titanium dioxide (E 171), gelatin.
Capsule (orange) - orange yellow FCF (E 110), titanium dioxide (E 171), gelatin.
Hard capsule, consisting of an opaque yellow body and an opaque orange cap.
30 or 60 capsules in a cardboard box.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Pierre Fabre Medicament, Les Cauquillous, 81500 Lavaur, France
Pierre Fabre Medicament Production, Etablissement Progipharm, Rue du Lycee B.P. 77, 45502 Gien, Cedex, France
Parallel importer:Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Repackaged by:Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Romanian marketing authorization number, country of export: 7293/2006/01
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.